Sign up to save your podcasts
Or
Share Mepolizumab for Eosinophilic COPD--Biologics Still Have Miles to Go
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Mepolizumab for Eosinophilic COPD--Biologics Still Have Miles to Go
Dr Andy Shorr comments on two trials of mepolizumab for patients with the eosinophilic phenotype of COPD.
View all episodes
By MedscapeDr Andy Shorr comments on two trials of mepolizumab for patients with the eosinophilic phenotype of COPD.